Third Pole Revenue, Growth & Competitor Profile

DBA THIRD POLE THERAPEUTICS

Company Profile & Annual Report for Third Pole

Access the complete profile.

Third Pole Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	54171 Research & Development in the Physical, Engineering & Life Sciences
Address	309 Waverley Oaks Rd Ste 404 Waltham, MA 02452

Note: Revenues for privately held companies are statistical evaluations.


Third Pole's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Third Pole's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Third Pole is classified as operating in the Research & Development in the Physical, Engineering & Life Sciences industry, NAICS Code 54171.

Third Pole Annual Revenue and Growth Rate

Third Pole	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$10 - $100 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Third Pole's revenues are gauged from an analysis of company filings.

Third Pole's Income Statement (based on Industry Averages)

Third Pole P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Third Pole is developing and marketing. Third Pole doesn't have any recent trademark applications, indicating Third Pole is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
NOBLE Pharmaceutical preparations for the treatment of infection, cancer, nephrology, urology, circulatory and blood disorders	04/27/2023
NOBLECARE Pharmaceutical preparations for the treatment of infection, cancer, nephrology, urology, circulatory and blood disorders	04/27/2023
VASONOBLE Pharmaceutical preparations for the treatment of infection, circulatory and blood disorders	04/27/2023

See all trademarks and details in the Full Report.

Market Share of Third Pole's Largest Competitors

A competitive analysis shows these companies are in the same general field as Third Pole, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
AXIOM SPACE	Houston, TX	1
ADVANCED CLINICAL HOLDINGS	Deerfield, IL	1
PONCE MEDICAL SCHOOL FOUNDATION	Ponce, PR	1
MARSHALL UNIVERSITY	Huntington, WV	1
RESEARCH INNOVATIONS	Alexandria, VA	1
VOYAGER SPACE HOLDINGS	Denver, CO	1
DEEP NORTH	Redwood City, CA	0
EPIRUS	Hawthorne, CA	0

Nearby Competitors

These companies are similar in business line and location to Third Pole. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
ELEVATEBIO IPSC	Waltham, MA	100
IMMUNOGEN	Waltham, MA	36
BOSTON IVF	Waltham, MA	34
NPS PHARMACEUTICALS	Lexington, MA	32
CLINICAL SERVICES CORPORATE OPERATIONS	Waltham, MA	20
FOSTER-MILLER	Waltham, MA	15

Future Competition: Third Pole's Fastest Growing Competitors

These companies are in the same general field as Third Pole and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)